Heart Test Laboratories Stock Analysis

Heart Stock Analysis Notes

The company recorded a loss per share of 1.09. Heart Test Laboratories had not issued any dividends in recent years. The entity had 1:100 split on the 17th of May 2024. Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. To learn more about Heart Test Laboratories call Andrew Simpson at 682 237 7781 or check out https://heartsciences.com.

Heart Test Laboratories Investment Alerts

Heart Profitablity

Management Efficiency

The company has return on total asset (ROA) of (0.7478) % which means that it has lost $0.7478 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.2042) %, meaning that it generated substantial loss on money invested by shareholders. Heart Test's management efficiency ratios could be used to measure how well Heart Test manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -4.06 in 2026. Return On Capital Employed is likely to climb to -17.56 in 2026. At this time, Heart Test's Non Current Assets Total are fairly stable compared to the past year. Total Current Assets is likely to climb to about 3.2 M in 2026, whereas Non Currrent Assets Other are likely to drop (349.4 K) in 2026.

Technical Drivers

As of the 6th of February, Heart Test retains the risk adjusted performance of 0.1165, and Market Risk Adjusted Performance of (1.99). Heart Test technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Heart Test Laboratories standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Heart Test is priced fairly, providing market reflects its last-minute price of 0.11 per share. As Heart Test Laboratories appears to be a penny stock we also urge to confirm its total risk alpha numbers.

Heart Test Laboratories Price Movement Analysis

Heart Test Laboratories Insider Trading Activities

Heart Test Outstanding Bonds

Heart Test Predictive Daily Indicators

Heart Test Forecast Models

Heart Test's time-series forecasting models are one of many Heart Test's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Heart Test's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Heart Test Bond Ratings

Heart Test Laboratories financial ratings play a critical role in determining how much Heart Test have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Heart Test's borrowing costs.

Heart Test Laboratories Debt to Cash Allocation

Heart Test Laboratories has accumulated 2.99 M in total debt. Heart Test Laboratories has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity.

Heart Test Total Assets Over Time

Heart Test Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Heart Test uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Heart Test Debt Ratio

116.0

It appears most of the Heart Test's assets are financed through debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Heart Test's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Heart Test, which in turn will lower the firm's financial flexibility.

Heart Test Corporate Bonds Issued

Heart Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Heart Test prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Heart shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Heart Test. By using and applying Heart Stock analysis, traders can create a robust methodology for identifying Heart entry and exit points for their positions.

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.